On July 9th, CONSUN PHARMA (01681) spent approximately 5.4584 million Hong Kong dollars to repurchase 48,900 shares.
Kangqiang Pharmaceutical (01681) announced the buyback of approximately HK$5.4584 million on July 9, 2025, repurchasing 48.9...
CONSUN PHARMA (01681) announced on July 9, 2025, that they will spend approximately HK$5.4584 million to repurchase 489,000 shares.
Related Articles
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
